Burcon NutraScience Corporation (OTCQB:BRCNF) Q1 2026 Earnings Conference Call August 13, 2025 5:00 PM ET
Company Participants
Kip Underwood – Chief Executive Officer
Paul Lam – Director of Investor Relations
Conference Call Participants
Bruce Lazenby – Unidentified Company
David Joseph Storms – Stonegate Capital Partners, Inc., Research Division
Operator
Good afternoon, everyone, and thank you for participating in today’s conference call to discuss Burcon NutraScience Corporation’s Fiscal 2026 First Quarter Results ended June 30, 2025. Joining us today are Kip Underwood, Burcon’s Chief Executive Officer; and Alex Varty, the company’s Interim Chief Financial Officer. [Operator Instructions] Then before we conclude today’s call, I’ll provide the company’s safe harbor statement with important cautions regarding the forward-looking statements made during this call.
Now I would like to turn the call over to the CEO of Burcon, Mr. Kip Underwood. Sir, please go ahead.
Kip Underwood
Thank you, operator. Good morning, good afternoon and good evening to those on the call today, and thank you for attending our Q1 conference call. Before we get started, I would like to preface this with we hope you all walk away with 3 fundamental takeaways. First, with our production facility in Galesburg, Illinois, working with our Alliance Partner, we have proven capability. We’ve proven we can produce our products at a cost and a quality that fully enable our business plan.
Second, the customer response to our products and the market growth for proteins, in particular, plant proteins has exceeded our expectations. Put those 2 together and the third key takeaway is, fundamentally, we are on track, we are on track to execute our business plan.
Our safe harbor statement, which the operator will read. So today, we’ll go through recent milestones. We’ll talk a little bit about our technology portfolio. It’s the foundation for our business, how we’ve integrated that technology
#Burcon #NutraScience #Corporation #BRCNF #Earnings #Call #Transcript